Applying lessons from the pandemic for non-invasive sample collection for infectious diseases

From saliva collection for COVID testing to urine self-sampling for HPV testing

Date:  Tuesday, July 26
Time: 7 - 8:30 a.m.
Location: Regency Ballroom A, Hyatt Regency
Supported by DNA Genotek

Overview

During the COVID-19 pandemic, there was an increased need for non-invasive, self-collection of samples for diagnostic testing for SARS-CoV-2 as well as at-home collection solutions for other infectious diseases, including detection of human papillomavirus (HPV), which can cause cervical cancers and other STI infections.

In this session, we’ll discuss the impact of the pandemic on using non-traditional sample types for diagnostic testing, including data on the benefits of utilizing saliva as a sample type for SARS-CoV-2 testing during a pandemic. We will also explore advances in utilizing first-void urine as a non-invasive, self-sampling method for detection of HPV.

Outcomes

After attending this session, participants will be able to:

  • Understand the contributing factors of the COVID-19 pandemic that highlighted the critical need for non-invasive (at-home) self-collection of samples for diagnostic testing.
  • Learn how utilizing saliva collection (in both adults and children) for SARS-CoV-2 testing enabled a clinical lab to support their community by providing non-invasive, self-collection of saliva samples for testing and variant monitoring.
  • Explore the advances in clinical data supporting first-void urine as a non-invasive, (at-home) self-collection sampling method for detection of HPV.

Moderator

Mara G. Aspinall

Managing Partner

Health Catalysts Group

Tucson, AZ

Speakers

Frank Middleton, PhD

Professor, Depts. of Neuroscience and Biochemistry; Director, SUNY Molecular Analysis Core

SUNY Upstate Medical University

Syracuse, NY

Jennifer S. Smith, PhD

Professor, Department of Epidemiology

University of North Carolina, Chapel Hill

Chapel Hill, NC